FDA Expands Testosterone Warning – National Attorneys Handling Androgel Lawsuits Provide New FDA Testosterone Warning Details at http://www.AndrogelTestosteroneLawsuitCenter.com

Lawyers representing national Androgel lawsuits at The Onder Law Firm update FDA warning information on testosterone risks and offer free Androgel lawsuit case review for individuals seeking to file an Androgel testosterone lawsuit related to heart attack or stroke.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

St. Louis, MO (PRWEB) June 23, 2014

Attorneys handling Androgel lawsuits at The Onder Law Firm are providing up-to-date Androgel information at their website, the Androgel Testosterone Lawsuit Center, in light of a June 19, 2014 testosterone warning announcement from the FDA*. The new FDA announcement states that the federal agency is now requiring testosterone products such as Androgel to include an additional, more general warning regarding the risk of blood clots on the products’ labels. This new requirement represents an expansion of the warnings regarding Androgel risks.

Testosterone products such as Androgel are the subject of an on-going FDA investigation** regarding the risk of heart attack, stroke, and other cardiovascular problems which, according to the new FDA safety update, are caused by blood clots in the arteries. The new FDA warning for testosterone cautions patients of the risk of blood clot development in the veins. Arterial blood clots, the FDA says, can result in heart attack, stroke, and other cardiovascular problems, whereas blood clots in the veins, or venous thromboembolism, cause serious health problems including deep vein thrombosis and pulmonary embolism.

The labels for Androgel and other testosterone replacement drugs already contain a warning for the risk of venous blood clots from a specific condition known as polycythemia, as stated by the new FDA testosterone alert. Polycythemia is described as an uncommon medical problem defined by an abnormally high red blood cell count that can occur in patients receiving testosterone replacement therapy. However, the recent FDA testosterone warning states that cases of deep vein thrombosis and pulmonary embolism unrelated to polycythemia have also been documented. The FDA is asking the makers of testosterone drugs like Androgel to expand the warning label contents to include a broader warning for venous thromboembolism.

To date, court documents*** show that Androgel lawsuits already filed against AbbVie are related to cases of stroke, heart attack, and death from testosterone replacement therapy. The same court documents indicate that at least 45 lawsuits have already been consolidated as a multi-district litigation in the Northern Illinois U.S. District Court in Chicago as In Re: Androgel Products Liability Litigation. The health risks cited in the existing testosterone Androgel lawsuits are under investigation by the FDA, as announced in a January 31, 2014 FDA testosterone Safety Communication**. The June 19, 2014 FDA testosterone safety alert concerns a separate health risk from Androgel and similar testosterone products. Androgel lawsuits regarding the new risks will not be included in this particular Androgel lawsuit multi-district litigation, as the consolidated cases only address cardiovascular problems such as heart attack and stroke, as defined in the court documents.

No amount of money can compensate families effectively for the loss of loved one, but an onslaught of Androgel lawsuits may help save other men from a similar fate by pressuring AbbVie to be more accountable for consumer safety. Lawyers handling Androgel cases at The Onder Law Firm believe qualifying persons may be entitled to real compensation through an Androgel lawsuit. Attorneys handling Androgel lawsuits announce no-cost, no-obligation case review to persons or family members of those who have suffered heart attack, stroke, or another serious health problem possibly related to Androgel or another testosterone drug. Interested persons may contact the firm via its Androgel Testosterone Lawsuit Center website.

The Onder Law Firm welcomes androgel lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from Androgel lawyers at http://www.androgeltestosteronelawsuitcenter.com.

*fda.gov/drugs/drugsafety/ucm401746.htm
**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm
***jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf


Contact

  • Michael Gudeman
    Gudeman Group
    +1 (314) 614-8709
    Email